Impact of adjuvant inhibition of vascular endothelial growth factor receptor tyrosine kinases on tumor growth delay and local tumor control after fractionated irradiation in human squamous cell carcinomas in nude mice

International Journal of Radiation Oncology Biology Physics

Volumn 61, Issue 3, 2005, Pages 908-914

  Zips, Daniel ^a   Hessel, Franziska ^a   Krause, Mechthild ^a   Schiefer, Yvonne ^a   Hoinkis, Cordelia ^a   Thames, Howard D ^b   Haberey, Martin ^c   Baumann, Michael ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF TEXAS   (United States)

^c BAYER PHARMA AG   (Germany)

Author keywords

Fractionated irradiation; Human tumor xenografts; PTK787 ZK222584; Squamous cell carcinoma; VEGFR inhibition

Indexed keywords

CELLS; DRUG DOSAGE; DRUG PRODUCTS; DRUG THERAPY; ENZYME INHIBITION; ENZYMES; GROWTH KINETICS; LIVING SYSTEMS STUDIES; RADIOTHERAPY;

ANGIOGENESIS; GROWTH RATE; TUMOR CELLS; TUMOR CONTROL;

TUMORS;

PROTEIN TYROSINE KINASE; VASCULOTROPIN RECEPTOR; VATALANIB;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELL LINE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; HYPOTHESIS; MALE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN TARGETING; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; TUMOR XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DOSE FRACTIONATION; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; MALE; MICE; MICE, INBRED STRAINS; MICE, NUDE; PHTHALAZINES; PROTEIN KINASE INHIBITORS; PYRIDINES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;

EID: 13844266132     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.11.007     Document Type: Article

References (45)

1. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1995 27 31
2. G. Bergers, L.E. Benjamin Tumorigenesis and the angiogenic switch Nat Rev Cancer 3 2003 401 410
3. H.F. Dvorak Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy J Clin Oncol 20 2002 4368 4380
4. N. Ferrara, H.P. Gerber, J. LeCouter The biology of VEGF and its receptors Nat Med 9 2003 669 676
5. J.M. Schlaeppi, J.M. Wood Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors Cancer Metastasis Rev 18 1999 473 481
6. R.K. Jain Tumor angiogenesis and accessibility: Role of vascular endothelial growth factor Semin Oncol 29 2002 3 9
7. D.H. Gorski, M.A. Beckett, N.T. Jaskowiak Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation Cancer Res 59 1999 3374 3378
8. C.G. Lee, M. Heijn, E. di Tomaso Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions Cancer Res 60 2000 5565 5570
9. L. Geng, E. Donnelly, G. McMahon Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy Cancer Res 61 2001 2413 2419
10. C. Hess, V. Vuong, I. Hegyi Effect of VEGF receptor inhibitor PTK787/ZK222584 [correction of ZK222548]combined with ionizing radiation on endothelial cells and tumour growth Br J Cancer 85 2001 2010 2016
11. S.V. Kozin, Y. Boucher, D.J. Hicklin Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts Cancer Res 61 2001 39 44
12. R.J. Griffin, B.W. Williams, R. Wild Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response Cancer Res 62 2002 1702 1706
13. V.K. Gupta, N.T. Jaskowiak, M.A. Beckett Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance Cancer J 8 2002 47 54
14. S. Ning, D. Laird, J.M. Cherrington The antiangiogenic agents SU5416 and SU6668 increase the antitumor effects of fractionated irradiation Radiat Res 157 2002 45 51
15. E.L. Lund, M.W. Olsen, K.E. Lipson Improved effect of an antiangiogenic tyrosine kinase inhibitor (SU5416) by combinations with fractionated radiotherapy or low molecular weight heparin Neoplasia 5 2003 155 160
16. D. Zips, M. Krause, F. Hessel Experimental study on different combination schedules of VEGF-receptor inhibitor PTK787/ZK222584 and fractionated irradiation Anticancer Res 23 2003 3869 3876
17. D.W. Siemann, W. Shi Targeting the tumor blood vessel network to enhance the efficacy of radiation therapy Semin Radiat Oncol 13 2003 53 61
18. P. Wachsberger, R. Burd, A.P. Dicker Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction Clin Cancer Res 9 2003 1957 1971
19. D. Zips, M. Baumann Anti-VEGF strategies in combination with radiotherapy C. Nieder L. Milas K.K. Ang Modification of radiation response: Cytokines, growth factors and other biological targets 2003 Springer Berlin, Heidelberg 179 188
20. O'Reilly MS. The combination of antiangiogenic therapy with other modalities. Cancer J 2002;8:S89-S99.
21. J.M. Wood, G. Bold, E. Buchdunger PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration Cancer Res 60 2000 2178 2189
22. G. Bold, K.H. Altmann, J. Frei New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis J Med Chem 43 2000 2310 2323
23. J.C. Tille, J. Wood, S.J. Mandriota Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro J Pharmacol Exp Ther 299 2001 1073 1085
24. A.L. Thomas, B. Morgan, J. Drevs Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584 Semin Oncol 30 2003 32 38
25. J. Drevs, R. Muller-Driver, C. Wittig PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging Cancer Res 62 2002 4015 4022
26. J. Drevs, I. Hofmann, H. Hugenschmidt Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model Cancer Res 60 2000 4819 4824
27. M.F. McCarty, C.H. Baker, C.D. Bucana Quantitative and qualitative in vivo angiogenesis assay Int J Oncol 21 2002 5 10
28. L. Xu, J. Yoneda, C. Herrera Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases Int J Oncol 16 2000 445 454
29. C.C. Solorzano, C.H. Baker, C.J. Bruns Inhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases Cancer Biother Radiopharm 16 2001 359 370
30. Steel G. Growth kinetics of tumours: Cell population kinetics in relation to the growth and treatment of cancer. Oxford: Clarendon Press; 1977.
31. Sachs L. Angewandte Statistik. 7th. ed. Berlin: Springer; 1992. p. 415.
32. D. Zips, W. Eicheler, K. Bruchner Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse Int J Radiat Biol 77 2001 1185 1193
33. C. Petersen, D. Zips, M. Krause Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation Int J Radiat Oncol Biol Phys 51 2001 483 493
34. M. Baumann, C. Petersen, J. Wolf No evidence for a different magnitude of the time factor for continuously fractionated irradiation and protocols including gaps in two human squamous cell carcinoma in nude mice Radiother Oncol 59 2001 187 194
35. A.M. Walker, H.D. Suit Assessment of local tumor control using censored tumor response data Int J Radiat Oncol Biol Phys 9 1983 383 386
36. Edwards A. Likelihood, extended edition. Baltimore: Johns Hopkins University Press; 1992.
37. J. Hast, I.B. Schiffer, B. Neugebauer Angiogenesis and fibroblast proliferation precede formation of recurrent tumors after radiation therapy in nude mice Anticancer Res 22 2002 677 688
38. O.V. Solesvik, E.K. Rofstad, T. Brustad Vascular changes in a human malignant melanoma xenograft following single-dose irradiation Radiat Res 98 1984 115 128
39. P. Vajkoczy, M. Farhadi, A. Gaumann Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2 J Clin Invest 109 2002 777 785
40. H. Yoshiji, S.R. Harris, U.P. Thorgeirsson Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells Cancer Res 57 1997 3924 3928
41. A.J. Schueneman, E. Himmelfarb, L. Geng SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models Cancer Res 63 2003 4009 4016
42. L.E. Benjamin, D. Golijanin, A. Itin Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal J Clin Invest 103 1999 159 165
43. A. Eberhard, S. Kahlert, V. Goede Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies Cancer Res 60 2000 1388 1393
44. M. Baumann, W. Dubois, H.D. Suit Response of human squamous cell carcinoma xenografts of different sizes to irradiation: Relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units Radiat Res 123 1990 325 330
45. M. Baumann, M. Krause Targeting the epidermal growth factor receptor in radiotherapy: Radiobiological mechanisms, preclinical and clinical results Radiother Oncol 72 2004 257 266